BioSpace News Archive

CSA Medical Inc. announced that it has secured $23 million in venture debt and equity financing to advance its two novel cryospray therapy platforms, truFreeze and Rejuvenair.

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2018 financial results after market close on Tuesday, November 6, 2018.

New analyses results reinforce effectiveness and safety for the use of TRULANCE in adults with CIC or IBS-C

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotechnology company, today announced the presentation of clinical data for IW-3718 and linaclotide from the company and its collaborators during the American College of Gastroenterology 2018 Annual Scientific Meeting in Philadelphia, PA, October 5

David Sinclair, PhD, co-founder and chairman of Life Biosciences Inc., has been appointed an Officer of the Order of Australia “for distinguished service of a high degree to Australia and humanity at large.”

TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced that FAREVA has selected TraceLink’s serialization solutions to ensure compliance with the EU Falsified Medicines Directive (FMD).

Company charts expanded direction and names new key additions

Denver-based psychiatrist Theodore Henderson, M.D., Ph.D and Dr. Larry Morries are revolutionizing the treatment of neurological disorders like depression, traumatic brain injury, Alzheimer’s disease, and Parkinson’s disease.

- Oral presentations include three of the five pivotal studies from AbbVie’s SELECT Phase 3 program to support regulatory submission for investigational upadacitinib in patients with moderate to severe rheumatoid arthritis

Paperless validation will help fuel fast paced advancements in life science research, translational and consumer genomics, and molecular diagnostics